Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, Katalin, Buckstein, Michael, Ni, Houping, Weissman, Drew·2005·Immunity
DOI 10.1016/j.immuni.2005.06.008

Cited by (1,004)

Items 801–900 of 1,004

  1. Emerging gene therapies for cystic fibrosis
    Kamran M. Miah, Stephen C. Hyde, Deborah R. Gill · 2019 · Expert Review of Respiratory Medicine
  2. A Census and Categorization Method of Epitranscriptomic Marks
    Julia Mathlin, Loredana Le Pera, Teresa Colombo · 2020 · International Journal of Molecular Sciences
  3. RNA Interference in Aquaculture: A Small Tool for Big Potential
    Haitham G. Abo‐Al‐Ela · 2021 · Journal of Agricultural and Food Chemistry
  4. The Epitranscriptome in Translation Regulation
    Eyal Peer, Sharon Moshitch-Moshkovitz, Gideon Rechavi, Dan Dominissini · 2018 · Cold Spring Harbor Perspectives in Biology
  5. Mitochondria-Induced Immune Response as a Trigger for Neurodegeneration: A Pathogen from Within
    Marta Luna‐Sánchez, Patrizia Bianchi, Albert Quintana · 2021 · International Journal of Molecular Sciences
  6. State‐of‐the‐art 2023 on gene therapy for phenylketonuria
    Michael Martinez, Cary O. Harding, Gerald Schwank, Beat Thöny · 2023 · Journal of Inherited Metabolic Disease
  7. Expedient production of site specifically nucleobase-labelled or hypermodified RNA with engineered thermophilic DNA polymerases
    Mária Brunderová, Vojtěch Havlíček, Ján Matyašovský, Radek Pohl, Lenka Poštová Slavětínská, Matouš Krömer, Michal Hocek · 2024 · Nature Communications
  8. Translocating gut pathobiont Enterococcus gallinarum induces T H 17 and IgG3 anti-RNA–directed autoimmunity in mouse and human
    Konrad Gronke, Mytien T. Nguyen, Helen Fuhrmann, Noemi Santamaria de Souza, Julia Schumacher, Márcia Santos Pereira, Ulrike Löschberger, Anna Brinkhege, Nathalie J. Becker, Yi Yang et al. · 2025 · Science Translational Medicine
  9. Human Toll-Like Receptor 8 Can Be Cool Too: Implications for Foreign RNA Sensing
    Soroush T. Sarvestani, Bryan R.G. Williams, Michael Paul Gantier · 2012 · Journal of Interferon & Cytokine Research
  10. Splenic RNA and MicroRNA Mimics Promote Complement Factor B Production and Alternative Pathway Activation via Innate Immune Signaling
    Lin Zou, Yan Feng, Ganqiong Xu, Wenling Jian, Wei Chao · 2016 · The Journal of Immunology
  11. Delivery of mRNA to platelets using lipid nanoparticles
    Stefanie K. Novakowski, K. Jiang, G. Prakash, Christian J. Kastrup · 2019 · Scientific Reports
  12. Virome–host interactions in intestinal health and disease
    Sang‐Uk Seo, Mi‐Na Kweon · 2019 · Current Opinion in Virology
  13. SARS-CoV-2 vaccines in patients with SLE
    Wei Tang, Anca Askanase, Leila Khalili, Joan T. Merrill · 2021 · Lupus Science & Medicine
  14. RNA-based therapeutics to treat human fungal infections
    Bruch, Alexander, Kelani, Abdulrahman A., Blango, Matthew G. · 2022 · Trends in Microbiology
  15. In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
    Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, Dmitri V. Krysko · 2023 · Vaccines
  16. Pseudouridine and N 1-methylpseudouridine as potent nucleotide analogues for RNA therapy and vaccine development
    Lyana L. Y. Ho, Gabriel H. A. Schiess, Pâmella Miranda, Gerald Weber, Kira Astakhova · 2024 · RSC Chemical Biology
  17. Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases
    Máté Vadovics, Hiromi Muramatsu, András Sárközy, Norbert Pardi · 2024 · Methods in molecular biology
  18. Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics
    Kuhn, Andreas N., Diken, Mustafa, Kreiter, Sebastian, Vallazza, Britta, Türeci, Özlem, Sahin, Ugur · 2011 · RNA Biology
  19. Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease
    Yoav Hadas, Michael G. Katz, Charles R. Bridges, Lior Zangi · 2016 · WIREs Systems Biology and Medicine
  20. The 'anti-hype' vaccine
    Laura DeFrancesco · 2017 · Nature Biotechnology
  21. Recommendations for COVID‐19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists
    Amelia Santosa, Chuanhui Xu, Thaschawee Arkachaisri, Kok Ooi Kong, Aisha Lateef, Tau Hong Lee, Keng Hong Leong, Andrea Hsiu Ling Low, Melonie Kannamma Sriranganathan, Teck Choon Tan et al. · 2021 · International Journal of Rheumatic Diseases
  22. Pharma 4.0 Continuous mRNA Drug Products Manufacturing
    Andreas Ouranidis, Christina Davidopoulou, Reald Tashi, Kyriakos Kachrimanis · 2021 · Pharmaceutics
  23. The Emerging Role of RNA Modifications in the Regulation of Antiviral Innate Immunity
    Jie Tong, Wuchao Zhang, Yuran Chen, Qiaoling Yuan, Ning-Ning Qin, Guosheng Qu · 2022 · Frontiers in Microbiology
  24. Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants
    Audrey W. Q. Lee, Florian Wimmers, Bali Pulendran · 2022 · Current Opinion in Immunology
  25. How RNA modifications regulate the antiviral response
    Matthew G. Thompson, Matthew T. Sacco, Stacy M. Horner · 2021 · Immunological Reviews
  26. The amphibian immune system
    Vania Lopez Ruiz, Jacques Robert · 2023 · Philosophical Transactions of the Royal Society B Biological Sciences
  27. A precise and efficient circular RNA synthesis system based on a ribozyme derived from Tetrahymena thermophila
    Jingyi Cui, Lanxin Zhang, Zaifeng Zhang, Xuanmei Luo, Ye Liu, Chang Li, Wei Huang, Lihui Zou, Xue Min Yu, Fei Xiao · 2023 · Nucleic Acids Research
  28. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
    R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti · 2024 · Annual Review of Immunology
  29. RNA m5C modification: from physiology to pathology and its biological significance
    Xi Chen, Yixiao Yuan, Fan Zhou, Xiaobing Huang, Lihua Li, Jun Pu, Yong Zeng, Xiulin Jiang · 2025 · Frontiers in Immunology
  30. In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
    Meltem Avci‐Adali, Andreas Behring, Heidrun Steinle, Timea Keller, Stefanie Krajeweski, Christian Schlensak, Hans Peter Wendel · 2014 · Journal of Visualized Experiments
  31. Deciphering the Code of Innate Immunity Recognition of siRNAs
    Mouldy Sioud · 2008 · Methods in molecular biology
  32. Emerging roles of the processing of nucleic acids and Toll-like receptors in innate immune responses to nucleic acids
    Kensuke Miyake, Takuma Shibata, Umeharu Ohto, Toshiyuki Shimizu · 2016 · Journal of Leukocyte Biology
  33. RNA ‐based therapies for genodermatoses
    Olivier Bornert, Patricia Peking, Jeroen Bremer, Ulrich Koller, Peter C. van den Akker, Annemieke M Aartsma-Rus, Anna M.G. Pasmooij, Eva Maria Murauer, Alexander Nyström · 2016 · Experimental Dermatology
  34. Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering
    Zohreh Sadat Badieyan, Todd Evans · 2019 · Stem Cells Translational Medicine
  35. Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA
    Heidrun Steinle, Marbod Weber, Andreas Behring, Ulrike Angelika Mau-Holzmann, Christian Schlensak, Hans Peter Wendel, Meltem Avci‐Adali · 2019 · Stem Cells International
  36. RNA-based therapy for osteogenesis
    Pinpin Wang, Federico Perche, Delphine Logeart‐Avramoglou, Chantal Pichon · 2019 · International Journal of Pharmaceutics
  37. Prediction of N6-methyladenosine sites using convolution neural network model based on distributed feature representations
    Muhammad Tahir, Maqsood Hayat, Kil To Chong · 2020 · Neural Networks
  38. Regulatory Considerations on the Development of mRNA Vaccines
    Ramachandra Naik, Keith Peden · 2020 · Current topics in microbiology and immunology
  39. The Key Role of Nucleic Acid Vaccines for One Health
    Anders Fomsgaard, Margaret A. Liu · 2021 · Viruses
  40. Emerging Perspectives of RNA N6-methyladenosine (m6A) Modification on Immunity and Autoimmune Diseases
    Lipeng Tang, Xingyan Wei, Tong Li, Yi Chen, Zhenhua Dai, Chuanjian Lu, Guangjuan Zheng · 2021 · Frontiers in Immunology
  41. In Vivo bone tissue induction by freeze-dried collagen-nanohydroxyapatite matrix loaded with BMP2/NS1 mRNAs lipopolyplexes
    Pinpin Wang, Federico Perche, Patrick Midoux, ‪Cátia S.D. Cabral, Virginie Malard, Ilídio Joaquim Correia, Hanane El‐Hafci, Hervé Petite, Delphine Logeart‐Avramoglou, Chantal Pichon · 2021 · Journal of Controlled Release
  42. Synthetic mRNA – emerging new class of drug for tissue regeneration
    Elizabeth Rosado Balmayor · 2021 · Current Opinion in Biotechnology
  43. Membrane-dependent relief of translation elongation arrest on pseudouridine- and N1-methyl-pseudouridine-modified mRNAs
    Yuri V. Svitkin, Anne‐Claude Gingras, Nahum Sonenberg · 2021 · Nucleic Acids Research
  44. mRNA and gene editing: Late breaking therapies in liver diseases
    Nerea Zabaleta, Laura Torella, Nicholas D. Weber, Gloria González‐Aseguinolaza · 2022 · Hepatology
  45. Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits
    Eric M. Mucker, Carolin Thiele-Suess, Patrick Baumhof, Jay W. Hooper · 2022 · Molecular Therapy — Nucleic Acids
  46. Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion
    Zhen Qin, Aurélie Bouteau, Christopher Herbst, Botond Z. Igyártó · 2022 · PLoS Pathogens
  47. One-Year Risk of Myocarditis After COVID-19 Infection: A Systematic Review and Meta-analysis
    Marco Zuin, Gianluca Rigatelli, Claudio Bilato, Aldostefano Porcari, Marco Merlo, Loris Roncon, Gianfranco Sinagra · 2022 · Canadian Journal of Cardiology
  48. From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
    Tetiana Korzun, Abraham S. Moses, Parham Diba, Ariana L. Sattler, Olena R. Taratula, Gaurav Sahay, Oleh Taratula, Daniel L. Marks · 2023 · Pharmaceuticals
  49. A Short History of Vaccination
    Susan L. Plotkin, Stanley Alan Plotkin · 2023 · Elsevier eBooks
  50. The Repeated Setbacks of HIV Vaccine Development Laid the Groundwork for SARS-CoV-2 Vaccines
    Jeffrey E. Harris · 2021 · National Bureau of Economic Research
  51. Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
    Nicholas M. Provine, Paul Klenerman · 2022 · European Journal of Immunology
  52. A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
    Marco Troisi, Eleonora Marini, Valentina Abbiento, Samuele Stazzoni, Emanuele Andreano, Rino Rappuoli · 2022 · Frontiers in Microbiology
  53. Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection
    Christina M. Kackos, Jennifer DeBeauchamp, Christopher J.H. Davitt, Jan Lonzarić, Robert E. Sealy, Julia L. Hurwitz, Marcelo M. Samsa, Richard J. Webby · 2023 · npj Vaccines
  54. Internal cap-initiated translation for efficient protein production from circular mRNA
    Kosuke Fukuchi, Yuko Nakashima, Naoko Abe, Seigo Kimura, Fumitaka Hashiya, Yuichi Shichino, Yiwei Liu, Ryoko Ogisu, Satomi Sugiyama, Daisuke Kawaguchi et al. · 2025 · Nature Biotechnology
  55. Quadruple adenine base–edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease–engineered T cells
    Nils W. Engel, Israel Steinfeld, Daniel Ryan, Kusala Anupindi, Samuel Kim, Nils Wellhausen, Linhui Chen, Katherine Wilkins, Daniel J. Baker, Philipp C. Rommel et al. · 2025 · Proceedings of the National Academy of Sciences
  56. Phagosomal TLR signaling upon Borrelia burgdorferi infection
    Jorge Cervantes, Kelly L. Hawley, Sarah J. Benjamin, Bennett Weinerman, Stephanie M. Luu, Juan C. Salazar · 2014 · Frontiers in Cellular and Infection Microbiology
  57. The Current Status of COVID-19 Vaccines
    Kenneth H. Lundstrom · 2020 · Frontiers in Genome Editing
  58. The role of N6-methyladenosine modification in the life cycle and disease pathogenesis of hepatitis B and C viruses
    Geon‐Woo Kim, Aleem Siddiqui · 2021 · Experimental & Molecular Medicine
  59. Aging through an epitranscriptomic lens
    Mary E. McMahon, Craig M. Forester, Rochelle Buffenstein · 2021 · Nature Aging
  60. Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses
    Sonia Ndeupen, Aurélie Bouteau, Christopher Herbst, Zhen Qin, Sonya Jacobsen, Nicholas E. Powers, Zachary Hutchins, Drishya Kurup, Leila Zabihi Diba, Megan Watson et al. · 2022 · PLoS Pathogens
  61. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
    Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, Labiba Mustabina Oishee, Mutia Masuka Muna · 2022 · RNA Biology
  62. The pathological maelstrom of COVID-19 and cardiovascular disease
    Mauro Giacca, Ajay M. Shah · 2022 · Nature Cardiovascular Research
  63. Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics
    Wei Yang, Jianwei Cao, Hui Cheng, Liang Chen, Meihua Yu, Yu Chen, Xingang Cui · 2022 · Bioactive Materials
  64. Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses
    Sibylle Tluk, Marion Jurk, Alexandra Forsbach, Risini D. Weeratna, Ulrike Samulowitz, ARTHUR M. KRIEG, Stefan Bauer, J. Vollmer · 2009 · International Immunology
  65. Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
    Aboshi, Masayuki, Matsuda, Kenta, Kawakami, Daisuke, Kono, Kaoru, Kazami, Yoko, Sekida, Takashi, Komori, Mai, Morey, Amber L., Suga, Shigeru, Smith, Jonathan F. et al. · 2024 · iScience
  66. RNA Binding Proteins as Pioneer Determinants of Infection: Protective, Proviral, or Both?
    Samantha M. Lisy, Katherine L. Rothamel, Manuel Ascano · 2021 · Viruses
  67. Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination
    Ran Kornowski, Guy Witberg · 2022 · Open Heart
  68. Nucleic DHX9 cooperates with STAT1 to transcribe interferon-stimulated genes
    Xingxing Ren, Decai Wang, Guorong Zhang, Tingyue Zhou, Zheng Wei, Yi Yang, Yunjiang Zheng, Xuqiu Lei, Wanyin Tao, An Min Wang et al. · 2023 · Science Advances
  69. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems
    Shiqi Wu, Lixin Lin, Lu Shi, Shuai Liu · 2024 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  70. Grand Challenges in Modulating The Immune Response with RNAi Nanomedicines
    Meir Goldsmith, Shoshy Mizrahy, Dan Peer · 2011 · Nanomedicine
  71. Generation of human induced pluripotent stem cells using non-synthetic mRNA
    Leili Rohani, C. Fabian, Heidrun Holland, Yahaira Naaldijk, Ralf Dressel, Henry Loeffler‐Wirth, Hans Binder, Antje Arnold, Alexandra Stolzing · 2016 · Stem Cell Research
  72. Intracellular RNA Sensing in Mammalian Cells: Role in Stress Response and Cancer Therapies
    Nikolai N. Khodarev · 2018 · International review of cytology
  73. Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA
    Bronwen J. Connor, Erin Firmin, Amy McCaughey‐Chapman, Ruth Monk, Kevin C. Lee, Sophie Liot, Johannes P. Geiger, Carsten Rudolph, Kathryn Jones · 2018 · Heliyon
  74. RNA is taking its Toll: Impact of RNA‐specific Toll‐like receptors on health and disease
    Tim Vierbuchen, Karina Stein, Holger Heine · 2018 · Allergy
  75. Dynamic Analysis of m6A Methylation Spectroscopy During Progression and Reversal of Hepatic Fibrosis
    Zhongqi Cui, Nan Jing Huang, Li Liu, Xue Li, Guohui Li, Yan Chen, Qi Wu, Jie Zhang, Shuping Long, Minyi Wang et al. · 2020 · Epigenomics
  76. mRNA delivery via non-viral carriers for biomedical applications
    Qi Shuai, Fangtao Zhu, Mengdan Zhao, Yunfeng Yan · 2021 · International Journal of Pharmaceutics
  77. Cytidine Acetylation Yields a Noninflammatory Synthetic Messenger RNA
    Kellie D. Nance, Supuni Thalalla Gamage, Md Masud Alam, Acong Yang, Michaella J. Levy, Courtney N. Link, Laurence A. Florens, Michael P. Washburn, Shuo Gu, Joost J. Oppenheim et al. · 2021 · Cell chemical biology
  78. Influenza Viruses: Innate Immunity and mRNA Vaccines
    SangJoon Lee, Jin‐Hyeob Ryu · 2021 · Frontiers in Immunology
  79. Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome
    Niklas-Benedikt Grimm, Jeannie T. Lee · 2022 · Trends in Genetics
  80. Complete Chemical Synthesis of Minimal Messenger RNA by Efficient Chemical Capping Reaction
    Naoko Abe, Akihiro Imaeda, Masahito Inagaki, Zhenmin Li, Daisuke Kawaguchi, Kaoru Onda, Yuko Nakashima, Satoshi Uchida, Fumitaka Hashiya, Yasuaki Kimura et al. · 2022 · ACS Chemical Biology
  81. m6A reader proteins: the executive factors in modulating viral replication and host immune response
    Decheng Yang, Guangze Zhao, Huifang Mary Zhang · 2023 · Frontiers in Cellular and Infection Microbiology
  82. A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection
    Adam J. Ronk, Nicole M. Lloyd, Min Zhang, Caroline G. Atyeo, Hailee R. Perrett, Chad E. Mire, Kathryn M. Hastie, Rogier W. Sanders, Philip J. M. Brouwer, Erica Ollmann Saphire et al. · 2023 · Nature Communications
  83. Nucleic Acid Recognition Receptors in Autoimmunity
    Anne Krug · 2007 · Handbook of experimental pharmacology
  84. Synthetically modified mRNA for efficient and fast human iPS cell generation and direct transdifferentiation to myoblasts
    David Preskey, Thomas F. Allison, Mark Jones, Kamel Mamchaoui, Christian A. Unger · 2015 · Biochemical and Biophysical Research Communications
  85. Inosine-Mediated Modulation of RNA Sensing by Toll-Like Receptor 7 (TLR7) and TLR8
    Soroush T. Sarvestani, Michelle D. Tate, Jessica M. Moffat, Ashley M. Jacobi, Mark A. Behlke, Alistair Miller, Simone A. Beckham, Claire E. McCoy, Weisan Chen, Justine D. Mintern et al. · 2013 · Journal of Virology
  86. The Toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery
    Anke Leichtle, Michelle Hernández, Kwang K. Pak, Nicholas J. G. Webster, Stephen I. Wasserman, Allen Frederic Ryan · 2009 · BMC Immunology
  87. RNA regulatory mechanisms that control antiviral innate immunity
    Nandan S. Gokhale, Julian R. Smith, Rachel D Van Gelder, Ram Savan · 2021 · Immunological Reviews
  88. Characterization of BNT162b2 mRNA to Evaluate Risk of Off-Target Antigen Translation
    Himakshi K. Patel, Kun Zhang, Rachael Utegg, Elaine Stephens, Shauna Salem, Heidi Welch, Svenja Grobe, Julia Schlereth, Andreas N. Kuhn, Jeff Ryczek et al. · 2023 · Journal of Pharmaceutical Sciences
  89. The RNA polymerase III–RIG-I axis in antiviral immunity and inflammation
    Leslie Naesens, Filomeen Haerynck, Michaela Ulrike Gack · 2023 · Trends in Immunology
  90. Development of nucleic acid medicines based on chemical technology
    Yusuke Kawamoto, You Wu, Yuki Takahashi, Yoshinobu Takakura · 2023 · Advanced Drug Delivery Reviews
  91. N6-methyladenosine modification—a key player in viral infection
    Xiaoyue Zhang, Peng Qiu, Lujuan Wang · 2023 · Cellular & Molecular Biology Letters
  92. mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
    Puthupparampil V. Scaria, Nicole Roth, Kim Schwendt, Olga V. Muratova, Nada Alani, Lynn Lambert, Emma K. Barnafo, Christopher G. Rowe, Irfan Zaidi, Kelly M. Rausch et al. · 2024 · npj Vaccines
  93. Epitranscriptome in action: RNA modifications in the DNA damage response
    Blerta Xhemalçe, Kyle M. Miller, Natalia Gromak · 2024 · Molecular Cell
  94. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
    Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, Seyedeh Habibeh Mirmajidi, Iman Zare, Yasaman Naeimzadeh, Atena Mansouri, Amir Tajbakhsh, Amir Savardashtaki, Amirhossein Sahebkar · 2024 · Journal of Nanobiotechnology
  95. Engineering Lipid Nanoparticles for mRNA Immunotherapy
    Robby C. Zwolsman, Youssef Bahaaeldin Darwish, Ewelina Kluza, Roy van der Meel · 2025 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  96. 3D Printing of Bioceramic Multifunctional Scaffolds for Bone Tissue Engineering
    Huifeng Shao, Kaikai Wen, Rong Liu, Na Ding, Youping Gong, Yiyu Zhuang, Yong He · 2025 · Advanced Functional Materials
  97. Mitochondrial RNA cytosolic leakage drives the SASP
    Stella G. Victorelli, Madeline Eppard, Hélène Martini, Seung‐Hwa Woo, Stacia P. A. Everts, Gung Lee, Nicholas Pirius, Nuan Han, Eugene Y. Liang, Ana Catarina Franco et al. · 2025 · Nature Communications
  98. Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
    Arwaf S. Alharbi, Aurélie Garcin, Kim A. Lennox, Solène Pradeloux, Christophe Wong, Sarah Straub, Roxane Valentin, Geneviève Pépin, Hongmei Li, Marcel F. Nold et al. · 2020 · Nucleic Acids Research
  99. Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins
    Andrew S. Khalil, Xiaohua Yu, Jennifer M. Umhoefer, Connie S. Chamberlain, Linzie A. Wildenauer, Gaoussou M. Diarra, Timothy A. Hacker, William L. Murphy · 2020 · Science Advances
  100. In Gratitude for mRNA Vaccines
    Lynda M. Stuart · 2021 · New England Journal of Medicine